Related Experiment Video
Updated: Sep 28, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Guillain-Barré syndrome associated with Coronavirus disease 2019: A case from Nepal
Roshan Aryal1, Shivaji Karki1, Shreesti Rajbhandari1
1Maharajgunj Medical Campus Institute of Medicine Tribhuvan University Kathmandu Nepal.
Insights
A rare neurological complication, Guillain-Barré syndrome, has been linked to Coronavirus disease 2019 (COVID-19). This case report details a patient in Nepal who developed Guillain-Barré syndrome following COVID-19 infection.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2.
- Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting peripheral nerves.
- GBS is a known potential post-infectious complication of various pathogens.
Observation:
- This report describes a case of GBS in a patient from Nepal.
- The patient developed GBS subsequent to a confirmed COVID-19 diagnosis.
Findings:
- The case demonstrates a correlation between COVID-19 infection and the development of Guillain-Barré syndrome.
- This association highlights GBS as a rare neurological complication of COVID-19.
Implications:
- Understanding the neurological complications of COVID-19 is crucial for patient management.
- Further research is warranted to elucidate the mechanisms linking SARS-CoV-2 and GBS.
- This case contributes to the global understanding of COVID-19's diverse clinical manifestations.
Abstract:
Coronavirus disease 2019 (COVID-19) has now spread widely after the outbreak since December 31, 2019. Guillain-Barré syndrome is an immunological postinfectious neuropathy, which has been reported to be a rare but possible complication COVID-19. We report a case of Guillain-Barré syndrome associated with COVID-19 in Nepal.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

